![Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis | SpringerLink Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F11630710-000000000-00000/MediaObjects/40257_2012_13040261_Fig2.jpg)
Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis | SpringerLink
![INDIVIDUAL ARTICLE: Vehicles Matter: Calcipotriene and Betamethasone Dipropionate Foam as a Topical Psoriasis Therapy - JDDonline - Journal of Drugs in Dermatology INDIVIDUAL ARTICLE: Vehicles Matter: Calcipotriene and Betamethasone Dipropionate Foam as a Topical Psoriasis Therapy - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/22_9_M7714_SF376528_Leo+Pharma+Enstilar_SUPPL2/Real-World-Evidence-on-the-Use-of-Calcipotriene-and---Betamethasone-Dipropionate-Aerosol-Foam-0.005%25-0.064%25-in--the-Treatment-of-Psoriasis--A-Review-of-Investigator-Initiated---Studies-Around-the-Globe_Figure1.png)
INDIVIDUAL ARTICLE: Vehicles Matter: Calcipotriene and Betamethasone Dipropionate Foam as a Topical Psoriasis Therapy - JDDonline - Journal of Drugs in Dermatology
![JCM | Free Full-Text | Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment JCM | Free Full-Text | Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment](https://www.mdpi.com/jcm/jcm-10-05589/article_deploy/html/images/jcm-10-05589-g001.png)
JCM | Free Full-Text | Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment
![Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) - ScienceDirect Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962220326256-gr1.jpg)
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) - ScienceDirect
![PDF] Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis | Semantic Scholar PDF] Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/22a7905676f40cb98a07534fa8ebb696a2b0c58b/4-Figure3-1.png)
PDF] Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis | Semantic Scholar
![The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes - JDDonline - Journal of Drugs in Dermatology The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/article_3621/Figure-1.jpg)